Glucose Buddy+ is a medical tracking app for diabetes management, offering blood sugar logging, medication tracking, and clinical reporting on iOS.
Product velocity
Steady
Daily rank 🇺🇸
#93
Medical · paid
Sentiment
4.8
3k reviews
Nemesis
mySugr - Diabetes Tracker Log
The App DNA
What makes this app unique?
Users hire the app to maintain a longitudinal health record for doctor visits, but the current monetization shift forces a trade-off between historical data access and subscription costs.
For Individuals managing diabetes who require blood glucose tracking, clinical data reporting, and professional health coaching.
Key features
12-week curriculum with 5-minute lessons for diabetes management
One-on-one messaging with certified diabetes educators
Hardware connectivity with Glucose Buddy Smart Meter
How much does it cost?
Subscription model anchored at $39.99/year, utilizing feature-gating for advanced analytics and ad-removal to drive conversion.
Velocity
Steady developmentShow more...
5 versions in history. Development pace: steady.
Who built it?
Azumio
7 apps tracked · Medical
Glucose Buddy Diabetes Tracker
Instant Fitness: Workout Trainer
Calorie Mama AI: Diet Counter
Argus: Pedometer Step Tracker
Sleep Time: Cycle Alarm Clock
Argus: Activity & Step TrackerUser Sentiment
What do users think recently?
The recent review mood reads frustrated. Users appreciate tracking blood sugar and medication logs provides essential health management for daily users.
How are ratings & reviews evolving?
What users say, by theme
- Tracking blood sugar and medication logs provides essential health management for daily users
- Aggressive paywall transitions restrict access to previously free historical data and insights
49 of 49 recent reviews analyzed · high confidence · Frustrated overall
Read the full review analysisUnlock 1 user request, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for Glucose Buddy+ for Diabetes
How's the Medical market?
The app holds a #80 Paid rank in the US Medical category, but the 4.8-star rating on 3,412 ratings masks the negative sentiment trend driven by recent paywall changes.
Read the market outlookThe rivals identified
By mySugr GmbH
Dominates the diabetes tracking niche with a massive user base and high-frequency release cadence that keeps the product ahead of market expectations.
- Gamified logging experience turns tedious data entry into a more engaging daily habit for users.
- Deep integration with continuous glucose monitors provides automated data streams that manual trackers cannot match.
- Aggressive release schedule of nine updates in six months ensures rapid feature iteration and bug resolution.
Unlock the head-to-head verdict: where this rival wins, and where it loses.
Access the full report for freeThe Analyst's Read
Key takeaways for Glucose Buddy+ for Diabetes
Where is it heading?
The diabetes tracking market is consolidating around automated data ingestion and gamified retention loops, leaving manual-entry apps like Glucose Buddy+ exposed. The current maintenance-mode update cadence fails to address the competitive pressure from hardware-integrated rivals, so the app will likely continue to lose market share unless it pivots to automated data streams.
- Technical instability during log entry disrupts the core health tracking habit, which compounds the rating drag already visible in recent reviews.
- The transition of legacy features to a subscription model drives user frustration, accelerating the shift toward more modern, automated tracking alternatives.
The SWOT
- Ten-year brand authority in diabetes management
- Clinical-grade PDF reporting for healthcare providers
- Automated activity data via wearable integration
- Refill alarms for medication adherence
Next best moves
Rebuild log-entry stability because barcode scanner crashes disrupt the core habit → increase retention
+ 1 more prioritized moveThe counter-intuitive read
The app's biggest risk is not a lack of features…
Read the full takeFeature gaps
Gamified logging experience (available in mySugr) +1
Since the last report: The app has pivoted to a restrictive subscription-gated model, causing a decline in user sentiment despite the addition of new professional coaching and hardware integration features.
Bottom line
The app maintains a strong clinical utility but risks alienating its legacy base through aggressive paywall gating, so the PM must prioritize stability and restore access to historical data to prevent churn to modern competitors.
Unlock 3 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeReport last updated